Previous Close | 0.2969 |
Open | 0.2885 |
Bid | 0.2881 x 1300 |
Ask | 0.2871 x 1000 |
Day's Range | 0.2822 - 0.2910 |
52 Week Range | 0.2800 - 2.6600 |
Volume | |
Avg. Volume | 1,119,026 |
Market Cap | 1.89M |
Beta (5Y Monthly) | 2.69 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -7.0500 |
Earnings Date | Nov 09, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.65 |
Subscribe to Yahoo Finance Plus to view Fair Value for NBY
EMERYVILLE, Calif., December 06, 2023--NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) announces its partnership with Woo University to support the education of eyecare professionals on the use of amniotic membranes. A free webinar is being held Thursday, December 7, 2023 from 5:30-6:30 pm Pacific time, and eyecare professionals can register here. In September 2023 NovaBay commercially launched its prescription amniotic membrane product Avenova® Allograft, which is intended for use as a prote
NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q3 2023 Earnings Call Transcript November 9, 2023 Operator: Welcome to the NovaBay Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to Ms. Jody Cain. Please go ahead, ma’am. Jody Cain: This […]
EMERYVILLE, Calif., November 09, 2023--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and nine months ended September 30, 2023 and provides a business update.